Hydromer, Inc. invents, develops, patents, licenses, manufactures, and sells hydrophilic polymer-based products and services in the United States and internationally. The company operates in two segments, Polymer Research and Medical Products. It offers medical coatings and services; medical hydrogel; cosmetic intermediaries; and anti-fog/anti-frost condensation control coating products. The company also provides cosmetics and personal care products, and watercraft hulls coating products; and engineering and contract coating services. It serves the medical, cosmetics, animal health, and industrial fields. Hydromer, Inc. was founded in 1980 and is based in Branchburg, New Jersey.
0 transactions — 0 buys and 0 sales reported by Hydromer, Inc. executives.
0 institutional funds report a position on HYDI in their latest SEC quarterly filing.
1 recent articles on HYDI.
Beyond raw data, we aggregate and score every smart money signal to give you a unique view.
8-dimension composite score: insiders · hedge funds · politicians · momentum · valuation · health · analysts · earnings.
Detection of clustered purchases or sales by several executives in the same stock.
Berkshire, Pershing Square, Tiger Global, Bridgewater and other reporting funds.
NANC & GOP (Pelosi & Republicans), GURU (top hedge funds), ARK (Cathie Wood). See who enters and exits each week.
Spot marked changes in search interest around the stocks being followed.
Create your watchlist and receive a brief of events affecting your tickers.
This public page only shows a preview. The full analysis of HYDI on the Kairos Insider dashboard includes:
Free signup · Pro €19/month or €190/year